SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer.
about
SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
SR-B1-targeted nanodelivery of ...... triple-negative breast cancer.
@ast
SR-B1-targeted nanodelivery of ...... triple-negative breast cancer.
@en
type
label
SR-B1-targeted nanodelivery of ...... triple-negative breast cancer.
@ast
SR-B1-targeted nanodelivery of ...... triple-negative breast cancer.
@en
prefLabel
SR-B1-targeted nanodelivery of ...... triple-negative breast cancer.
@ast
SR-B1-targeted nanodelivery of ...... triple-negative breast cancer.
@en
P2093
P2860
P356
P1476
SR-B1-targeted nanodelivery of ...... triple-negative breast cancer.
@en
P2093
Andras G Lacko
Nirupama Sabnis
Rebecca Johnson
Ruhani Ahluwalia
Xiangle Sun
P2860
P304
P356
10.2147/BCTT.S131038
P577
2017-06-02T00:00:00Z